Search
for
Sort by
Research 721–750 of 1000+
- DERMATOLOJİK ACİLLER
- Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
- Drug Eruptions
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion after Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – an Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications
- Finasteride-Induced Neuropsychiatric Reactions Are Well Established
- Eczema-Like Psoriasiform Skin Reaction due to Brazilian Keratin Treatment
- Nurses' Drug Alert
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Psoriatic Alopecia/Alopecia Areata‐Like Reactions Secondary to Anti‐Tumour Necrosis Factor‐Alpha Therapy
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- Impact of Chemotherapeutic Drug on People living with Cancer
- Dipyridamole-Associated Shock and Pulmonary Edema; Oxcarbazepine-Induced Resistant Ventricular Fibrillation; Finasteride-Induced Pseudoporphyria; Suicidal Ideation Associated with Asenapine; Rediscovering Adverse Anticholinergic Effects; Prevalence of Adverse Drug Events in Ambulatory Care
- 1. Medical Practice; Therapy; Adverse Reactions
- Tolerability of hair cleansing conditioners: a double-blind randomized, controlled trial designed to evaluate consumer complaints to the U.S. Food and Drug Administration
- Phenobarbital
- WARFARIN
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Fluoxetine- and Sertraline-Related Hair Loss in a Teenager: A Case Report
- Cutaneous complications of chemotherapeutic agents
- Minoxidil and pericardial effusion: An idiosyncratic reaction
- <i>peri</i> ‐Xanthenoxanthene (PXX): a Versatile Organic Photocatalyst in Organic Synthesis
- SDRIFE Induced by Tofacitinib
- Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy
- Melasma and other skin manifestations or oral contraceptives.
- Adverse Reactions to Enemas